These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1250243)

  • 1. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor.
    Osterman-Golkar S; Ehrenberg L; Segerbäck D; Hällström I
    Mutat Res; 1976 Jan; 34(1):1-10. PubMed ID: 1250243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of alkylated proteins in the monitoring of exposure to alkylating agents.
    Farmer PB; Bailey E; Campbell JB
    IARC Sci Publ; 1984; (59):189-98. PubMed ID: 6545280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo.
    Ehrenberg L; Osterman-Golkar S; Segerbäck D; Svensson K; Calleman CJ
    Mutat Res; 1977 Nov; 45(2):175-84. PubMed ID: 593285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation and subsequent removal of O6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine.
    Pegg AE; Hui G
    Biochem J; 1978 Sep; 173(3):739-48. PubMed ID: 708371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylation of rat liver DNA by dimethylnitrosamine: effect of dosage on O6-methylguanine levels.
    Pegg AE
    J Natl Cancer Inst; 1977 Mar; 58(3):681-7. PubMed ID: 839563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationships between alkylation of haemoglobin and DNA in Fischer 344 rats exposed to [14C]ethylene oxide.
    Potter D; Blair D; Davies R; Watson WP; Wright AS
    Arch Toxicol Suppl; 1989; 13():254-7. PubMed ID: 2774941
    [No Abstract]   [Full Text] [Related]  

  • 7. Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide.
    Segerbäck D
    Chem Biol Interact; 1983 Jul; 45(2):139-51. PubMed ID: 6883570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis.
    Montesano R
    J Supramol Struct Cell Biochem; 1981; 17(3):259-73. PubMed ID: 7328674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of cysteine in hemoglobin following exposure to methylating agents.
    Bailey E; Connors TA; Farmer PB; Gorf SM; Rickard J
    Cancer Res; 1981 Jun; 41(6):2514-7. PubMed ID: 7237445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.
    Peterson LA; Thomson NM; Crankshaw DL; Donaldson EE; Kenney PJ
    Cancer Res; 2001 Aug; 61(15):5757-63. PubMed ID: 11479212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased excision of O6-methylguanine from rat liver DNA after chronic administration of dimethylnitrosamine.
    Montesano R; Brésil H; Margison GP
    Cancer Res; 1979 May; 39(5):1798-802. PubMed ID: 427812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and loss of alkylated purines from DNA of hamster liver after administration of dimethylnitrosamine.
    Stumpf R; Margison GP; Montesano R; Pegg AE
    Cancer Res; 1979 Jan; 39(1):50-4. PubMed ID: 761197
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenicity of dimethylnitrosamine to mammalian cells as determined by the use of mouse liver microsomes.
    Umeda M; Saito M
    Mutat Res; 1975 Nov; 30(2):249-54. PubMed ID: 1207708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of in vivo alkylation of haemoglobin and DNA using gas chromatography-mass spectrometry.
    Farmer PB; Bailey E; Shuker DE
    Dev Toxicol Environ Sci; 1983; 11():273-80. PubMed ID: 6677462
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutational response at the splenic T-lymphocyte hprt locus in mice treated as neonates: contrasting effects of the carcinogens N-ethyl-N-nitrosourea, dimethylnitrosamine, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Dass SB; Heflich RH; Casciano DA
    Environ Mol Mutagen; 1998; 31(3):243-7. PubMed ID: 9585262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes.
    Umbenhauer DR; Pegg AE
    Cancer Res; 1981 Sep; 41(9 Pt 1):3471-4. PubMed ID: 7260909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of genetic risks of alkylating agents. VI. Exposure of mice and bacteria to methyl bromide.
    Djalali-Behzad G; Hussain S; Osterman-Golkar S; Segerbäck D
    Mutat Res; 1981 Nov; 84(1):1-9. PubMed ID: 7035924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and the relationship to carcinogenicity.
    Devereux TR; Anderson MW; Belinsky SA
    Cancer Res; 1988 Aug; 48(15):4215-21. PubMed ID: 3390815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to the quantitation of alkylated amino acids in haemoglobin by gas chromatography mass spectrometry.
    Farmer PB; Bailey E; Lamb JH; Connors TA
    Biomed Mass Spectrom; 1980 Jan; 7(1):41-6. PubMed ID: 7397319
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of extracorporeal alkylation of red cells as a potential treatment for sickle cell anemia.
    Charache S; Dreyer R; Zimmerman I; Hsu CK
    Blood; 1976 Mar; 47(3):481-8. PubMed ID: 1252617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.